Adoptive therapy with <scp>cytomegalovirus</scp> ‐specific T cells for <scp>cytomegalovirus</scp> infection after haploidentical stem cell transplantation and factors affecting efficacy-Reference-Cited by-同舟云学术

Adoptive therapy with cytomegalovirus ‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy

Published:2022-03-25 Issue:6 Volume:97 Page:762-769
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Pei Xu‐Ying¹^ORCID,Zhao Xiang‐Yu¹^ORCID,Liu Xue‐Fei¹²,Mo Xiao‐Dong¹^ORCID,Lv Meng¹,Xu Lan‐Ping¹,Wang Yu¹^ORCID,Chang Ying‐Jun¹^ORCID,Zhang Xiao‐Hui¹^ORCID,Liu Kai‐Yan¹^ORCID,Huang Xiao‐Jun¹²^ORCID

Affiliation:

1. Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation Beijing China

2. Peking‐Tsinghua Center for Life Sciences Beijing China

Funder

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26535

Reference41 articles.

1. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality